BioSpace News Archive

Business

Magellan Health Reports Second Quarter 2019 Financial Results and Confirms Full Year Guidance

Magellan Health, Inc. announced financial results for the second quarter ended June 30, 2019

July 30, 2019
·
10 min read
Business

Waters Corporation (NYSE: WAT) Reports Second Quarter 2019 Financial Results

Waters Corporation announced second quarter 2019 sales of $599 million, which were flat as reported, compared to sales of $596 million for the second quarter of 2018.

July 30, 2019
·
18 min read
Business

Merck Announces Second-Quarter 2019 Financial Results

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced financial results for the second quarter of 2019.

July 30, 2019
·
33 min read
Business

XORTX Announces Virtual Investor Conference Live Webcast

XORTX Therapeutics Inc. is pleased to announce that Dr. Allen Davidoff, CEO, will be presenting at VirtualInvestorConferences.com on August 1st, a live, interactive online event where investors are invited to ask the Company questions in real-time – see details below.

July 30, 2019
·
3 min read
Deals

Welsh, Carson, Anderson & Stowe Raises $4.3 Billion in Oversubscribed Thirteenth Private Equity Fund

WCAS XIII Will Focus on WCAS’s Proven Strategy of Building Leading Technology and Healthcare Companies

July 30, 2019
·
4 min read
Business

Acerus And Aytu Bioscience To Co-Promote NATESTO® In The United States

Acerus Pharmaceuticals Corporation announced that it will be taking an expanded role in the commercialization of NATESTO® in the U.S. The company has entered into an amended and restated licensing agreement with Aytu BioScience, Inc.

July 30, 2019
·
8 min read
Deals

Cantel to Acquire Hu-Friedy

Cantel Medical Corp., a global leader in instrument reprocessing and innovative infection prevention products and services, announced that it has entered into a definitive agreement to acquire privately-held Hu-Friedy Mfg.

July 30, 2019
·
13 min read
Deals

CytoSorbents to Report Q2 2019 Operating and Financial Results

CytoSorbents Corporation, a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, will report Q2 2019 financial results after the market close on Tuesday, August 6, 2019.

July 30, 2019
·
4 min read
Deals

Ionis Pharmaceuticals to hold second quarter 2019 financial results webcast

Webcast scheduled for Wednesday, August 7th at 11:30 a.m. Eastern Time

July 30, 2019
·
1 min read
Business

Incyte Reports 2019 Second Quarter Financial Results and Provides Updates on Key Clinical Programs

Incyte Corporation reports 2019 second quarter financial results and provides a status update on the Company’s development portfolio.

July 30, 2019
·
22 min read